Research and development (R&D) expenses for the fourth quarter and full year 2024 were $1.3 million and $10.5 million, respectively, compared to $9.7 million and $40.0 million for the same periods in ...

BridgeBio could be an acquisition target, but current financial challenges and competition suggest a "Hold" rating until ...

Elon Musk’s Department of Government Efficiency is here, and defense contractors can’t wait for the “revolution” to reach the ...

Despite loud statements about leaving, the American company Pfizer continues to promote its drugs in Russia, using opaque schemes, and transfers part of the income to the Armed Forces of Ukraine.

Six deaths reported this past week in McLeod County were attributed to COVID-19, according to data from the Minnesota Department of Health. It was the deadliest week of the pandemic since last ...

Aims to boost health awareness for migraine, disease impacting over 900,000 Hongkongers HONG KONG, Feb. 7, 2025 /PRNewswire/ -- Bowtie, Hong Kong's first ...

James initiated coverage on Regenxbio Inc . (NASDAQ:RGNX), bestowing an Outperform rating and setting a price target of $27.00 for the biotechnology company's shares. The firm's endorsement comes with ...

Come March, Medicare patients who meet income eligibility, which is at or below 300% of the Federal Poverty Level, and are either underinsured for Part D or don’t have that coverage altogether, may ...

Pfizer joins Minnesota and Company to discuss how to protect yourself by scheduling your vaccines to prevent serious consequences.

The pharmaceutical giant sold its flex building at the Imperial Center for $41.1 million to New York-based Lightstone Group, ...

We recently compiled a list of the 12 Best 5% Dividend Stocks To Buy According To Hedge Funds. In this article, we are going to take a look at where Pfizer Inc.

A Huntsville-based biotechnology company has secured $10 million in funding to begin the trial of a new way to deliver medication to advanced Parkinson’s disease patients.